Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-02-20 @ 6:41 PM
Study NCT ID:
NCT02841150
Status:
COMPLETED
Last Update Posted:
2018-03-29
First Post:
2016-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
Sponsor:
Janssen Research & Development, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: